Sign up for free insights newsletter
Pfizer Inc

Pfizer Inc

PFEXETRA (Frankfurt)

Need professional-grade analysis? Visit stockanalysis.com

€23.38
+0.02%
End of day
Market Cap

$133.89B

P/E Ratio

16.70

Employees

81,000

Dividend Yield

634.00%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-3.142.074.602.720.31-0.021.36
Calmar-35.269.4312.173.680.24-0.011.80
Sharpe-3.101.432.621.480.20-0.010.72
Omega0.011.301.501.301.061.021.13
Martin-43.4717.7234.137.630.59-0.016.39
Ulcer1.301.491.635.058.6336.4112.73

Pfizer Inc (PFE) Price Performance

Pfizer Inc (PFE) trades on XETRA (Frankfurt) in EUR. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at EUR23.38, up 0.02% from the previous close.

Over the past year, PFE has traded between a low of EUR17.65 and a high of EUR23.75. The stock has gained 6.2% over this period. It is currently 32.5% above its 52-week low.

Pfizer Inc has a market capitalization of $133.89B, with a price-to-earnings ratio of 16.70 and a dividend yield of 634.00%.

About Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. has strategic collaboration with Boltz, PBC to develop and deploy state-of-the-art biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Company Info

Exchange
XETRA (Frankfurt)
Currency
EUR
Country
Germany

Financial Metrics

Revenue (TTM)
$62.58B
EBITDA
$25.72B
Profit Margin
12.42%
EPS (TTM)
1.18
Book Value
13.12

Technical Indicators

52 Week High
€23.89
52 Week Low
€17.36
50 Day MA
€22.58
200 Day MA
€21.16
Beta
0.41

Valuation

Trailing P/E
19.81
Forward P/E
N/A
Price/Sales
2.14
Price/Book
1.78
Enterprise Value
$187.27B